Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
To test whether treatment with the angiotensin II receptor antagonist Irbesartan improves
insulin sensitivity and metabolic profile in patients with chronic heart failure.